United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,481 | 68,521 | 68,362 | 86,443 | 91,067 |
| Marketable Securities | N/A | N/A | 200 | N/A | N/A |
| Receivables | 10,199 | 7,880 | 10,693 | 9,287 | 10,451 |
| Inventories | 7,326 | 7,805 | 8,116 | 7,676 | 7,510 |
| Other current assets | 1,647 | 1,760 | 476 | 359 | 578 |
| TOTAL | $95,391 | $88,288 | $89,721 | $105,327 | $111,202 |
| Non-Current Assets | |||||
| PPE Net | 17,175 | 15,199 | 15,225 | 11,375 | 11,183 |
| Investments And Advances | 54,541 | 54,216 | 55,996 | 55,308 | 45,658 |
| Intangibles | 13,671 | 13,791 | 13,911 | 14,128 | 14,343 |
| Other Non-Current Assets | 2,472 | 4,546 | 4,649 | 1,948 | 2,282 |
| TOTAL | $87,859 | $87,752 | $89,781 | $82,759 | $73,466 |
| Total Assets | $183,250 | $176,040 | $179,502 | $188,086 | $184,668 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20 | 22 | 773 | 2,478 | 1,095 |
| Accounts payable and accrued liabilities | 2,643 | 3,338 | 4,326 | 4,413 | 3,056 |
| Accrued Expenses | 7,593 | 6,402 | 5,459 | 9,452 | 7,221 |
| Other current liabilities | 62 | 61 | 59 | 59 | 58 |
| TOTAL | $11,302 | $9,823 | $10,618 | $17,451 | $12,466 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16 | 20 | 25 | 31 | 1,739 |
| Other Non-Current Liabilities | 1,347 | 1,143 | 1,094 | 1,054 | 997 |
| TOTAL | $1,363 | $1,163 | $1,119 | $1,085 | $2,736 |
| Total Liabilities | $12,665 | $10,986 | $11,737 | $18,536 | $15,202 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,906 | 42,751 | 42,665 | 42,584 | 42,449 |
| Common Shares | 220 | 219 | 218 | 218 | 217 |
| Retained earnings | -193,497 | -197,637 | -195,790 | -192,570 | -191,229 |
| Other shareholders' equity | 602 | 214 | 1,800 | 783 | 909 |
| TOTAL | $170,585 | $165,054 | $167,765 | $169,550 | $169,466 |
| Total Liabilities And Equity | $183,250 | $176,040 | $179,502 | $188,086 | $184,668 |